EGFR Positive Lung Cancer UK shared a post on X:
“New ASCO guidance for advanced EGFR+ lung cancer shows how fast treatment pathways are changing. More options, more combinations, more flexibility in how treatment’s sequenced. But in the UK, access lags behind evidence. Our EGFR+ UK community deserves the same treatment choices reflected in international guidance.”
Title: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0
Authors: Sonam Puri, Natasha B. Leighl, Nofisat Ismaila, Fawzi Abu Rous, Amith Ahluwalia, Krishna Alluri, Ibrahim Hanna Azar, Toby Campbell, Greg Durm, Jill Feldman, Narjust Florez, Janet Freeman-Daily, Naoki Furuya, Shirish Gadgeel, Balazs Halmos, Hidehito Horinouchi, Sara Kuruvilla, Gary R. MacVicar, Narinder Malhotra, Kristen Ashley Marrone, Deebya Raj Mishra, Michael Mullane, Jarushka Naidoo, Dwight H. Owen, Bruna Pellini, Carolyn J. Presley, Angel Qin, Logan Roof, Erin L. Schenk, Lecia Sequist, Navneet Singh, Eric K. Singhi, Jennifer Marie Suga, Ana I. Velazquez, Yubao Wang, Paul Wheatley Price, Joshua E. Reuss, Lyudmila Bazhenova
Read The Full Article
‘
More posts about EGFR on OncoDaily.